Global Apolipoprotein Testing Market By Indication (Cardiovascular Disorders, Hypertension, Obesity), By End-User (Hospitals, Clinical Laboratories, Ambulatory Surgical Centers, Diagnostic Laboratories), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031
- account_circleAbout Me
- 74578
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
Apolipoprotein testing aids in the detection of the risk of cardiovascular diseases. The level of apolipoprotein in the blood is determined by apolipoprotein testing. Apolipoprotein testing differs depending on the patient's age, gender, and medical history.
Apolipoprotein testing is commonly performed in individuals who are obese, have a drug addiction, or smoking habits, among other factors. This testing is used to determine the amount of High-Density Lipoprotein (HDL) cholesterol in the body. Apolipoprotein levels in the blood should be between 110 and 233 mg/dl. Apolipoprotein testing requires a blood sample from an arm vein.
Apolipoprotein testing may be combined with other lipid tests, with the additional lipid testing confirming the apolipoprotein results. When it comes to apolipoprotein testing, a physician may recommend both the Apo A-I and Apo B tests. Knowing the levels of both apolipoproteins can help determine good and bad cholesterol levels.
Detailed Segmentation –
Based on Indication:
- Cardiovascular Disorders
- Hypertension
- Obesity
- Other Indications
Based on End-User:
- Hospitals
- Clinical Laboratories
- Ambulatory Surgical Centers
- Diagnostic Laboratories
Based on Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Market Dynamics –
Drivers for the Global Apolipoprotein Testing Market:
The surging need for diagnostic services in developing countries is one of the primary factors fueling the economic growth of the apolipoprotein test market. Increased awareness of the need of maintaining good cardiac health could boost the market for apolipoprotein tests.
Unhealthy living choices contribute to a surge in the number of significant cardiovascular disorders such as coronary heart disease, high blood pressure, cardiac arrest, heart failures, strokes, arrhythmia, and many other diseases, in turn increasing the demand for apolipoprotein tests.
Most physicians, heart specialists, and healthcare providers now prescribe an apolipoprotein test to patients who have a personal family history of heart disease and is thought to be one of the major factors augmenting the apolipoprotein test market's economic growth.
Restraint Global Apolipoprotein Testing Market:
The lack of understanding of atherosclerosis-related issues by individuals could stymie the revenue growth of the apolipoprotein testing market.
Opportunities for the Global Apolipoprotein Testing Market:
Among geriatric populations, those with hypertension and high blood pressure-related complications, apolipoprotein testing plays a significant role in disease diagnosis. Therefore, the apolipoprotein testing market is expected to index significant revenue growth in both hypertension and high blood pressure segments. The market for apolipoprotein testing is anticipated to expand in tandem with the increasing frequency of obesity among those aged 30 to 40.
Trends for the Global Apolipoprotein Testing Market:
Owing to a surging number of individuals suffering from cardiac related issues, the apolipoprotein testing market is expected to increase rapidly over the forecast period. With an immense number of individuals suffering from heart attacks and strokes, cardiovascular disease is the leading segment for apolipoprotein testing.
Competitive Landscape –
- Mabtech AB
- Abcam plc.
- R&D Systems Inc.
- Thermo Fisher Scientific Inc.
- Elabscience Biotechnology Inc.
- Aviva Systems Biology Corporation
- Wuhan USCN Business Co. Ltd.
- Kamiya Biomedical Company
- Randox Laboratories Ltd.
- Bio-Rad Laboratories Inc.
- Eagle Biosciences Inc.
- Biocompare
Recent Developments of Major Players –
- In May, 2017, Bio-Plex Pro Human Apolipoprotein was developed by Bio-Rad Labs Inc. It allows researchers to detect nine major apolipoproteins and C-reactive protein in human samples, allowing them to obtain new insights into cardiovascular and neurological illnesses.
- In January, 2018, Nittobo America Inc. announced the acquisition of Kamiya Biomedical Company to develop its operations in the United States.
For the Apolipoprotein Testing Market research study, the following years have been considered to estimate the market size:
Particular Scope Region - North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Historic Year 2016 to 2020 Base Year 2021 Estimated Year 2022 Forecast Year 2023 to 2032 - account_circleAbout Me
- 74578
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
- 1.Apolipoprotein Testing Market Introduction
- 1.1.Definition
- 1.2.Taxonomy
- 1.3.Research Scope
- 2.Executive Summary
- 2.1.Key Findings by Major Segments
- 2.2.Top strategies by Major Players
- 3.Global Apolipoprotein Testing Market Overview
- 3.1.Apolipoprotein Testing Market Dynamics
- 3.1.1.Drivers
- 3.1.2.Opportunities
- 3.1.3.Restraints
- 3.1.4.Challenges
- 3.2.COVID-19 Impact Analysis
- 3.3.COVID-19 Impact Analysis in Global Apolipoprotein Testing Market
- 3.4.PESTLE Analysis
- 3.5.Opportunity Map Analysis
- 3.6.PORTER'S Five Forces Analysis
- 3.7.Market Competition Scenario Analysis
- 3.8.Product Life Cycle Analysis
- 3.9.Opportunity Orbits
- 3.10.Manufacturer Intensity Map
- 3.11.Major Companies sales by Value & Volume
- 3.1.Apolipoprotein Testing Market Dynamics
- 4.Global Apolipoprotein Testing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Based on Indication, 2016-2032
- 4.1.Global Apolipoprotein Testing Market Analysis by Based on Indication: Introduction
- 4.2.Market Size and Forecast by Region
- 4.3.Cardiovascular Disorders
- 4.4.Hypertension
- 4.5.Obesity
- 4.6.Other Indications
- 5.Global Apolipoprotein Testing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by End-User, 2016-2032
- 5.1.Global Apolipoprotein Testing Market Analysis by End-User: Introduction
- 5.2.Market Size and Forecast by Region
- 5.3.Hospitals
- 5.4.Clinical Laboratories
- 5.5.Ambulatory Surgical Centers
- 5.6.Diagnostic Laboratories
- 6.Global Apolipoprotein Testing Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2016-2032
- 6.1.North America
- 6.1.1.North America Apolipoprotein Testing Market: Regional Trend Analysis
- 6.1.1.1.U.S.
- 6.1.1.2.Canada
- 6.1.1.3.Mexico
- 6.1.1.North America Apolipoprotein Testing Market: Regional Trend Analysis
- 6.2.1.Europe
- 6.2.1.Europe Apolipoprotein Testing Market: Regional Trend Analysis
- 6.2.1.1.U.K.
- 6.2.1.2.Germany
- 6.2.1.3.France
- 6.2.1.4.Spain
- 6.2.1.5.Italy
- 6.2.1.6.Russia
- 6.2.1.7.Rest of Europe
- 6.2.1.Europe Apolipoprotein Testing Market: Regional Trend Analysis
- 6.3.Asia-Pacific
- 6.3.1.Asia-Pacific Apolipoprotein Testing Market: Regional Trend Analysis
- 6.3.1.1.China
- 6.3.1.2.Japan
- 6.3.1.3.South Korea
- 6.3.1.4.India
- 6.3.1.5.ASEAN
- 6.3.1.6.Rest of Asia-Pacific
- 6.3.1.Asia-Pacific Apolipoprotein Testing Market: Regional Trend Analysis
- 6.4.Latin America
- 6.4.1.Latin America Apolipoprotein Testing Market: Regional Trend Analysis
- 6.4.1.1.Brazil
- 6.4.1.2.Argentina
- 6.4.1.3.Rest of Latin America
- 6.4.1.Latin America Apolipoprotein Testing Market: Regional Trend Analysis
- 6.5.Middle East and Africa
- 6.5.1.Middle East and Africa Apolipoprotein Testing Market: Regional Trend Analysis
- 6.5.1.1.GCC
- 6.5.1.2.Israel
- 6.5.1.3.South Africa
- 6.5.1.4.Rest of MEA
- 6.5.1.Middle East and Africa Apolipoprotein Testing Market: Regional Trend Analysis
- 6.1.North America
- 7.Global Apolipoprotein Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1.Market Share Analysis
- 7.2.Company Profiles
- 7.3.Mabtech AB
- 7.3.1.Company Overview
- 7.3.2.Financial Highlights
- 7.3.3.Product Portfolio
- 7.3.4.SWOT Analysis
- 7.3.5.Key Strategies and Developments
- 7.4.Abcam plc.
- 7.4.1.Company Overview
- 7.4.2.Financial Highlights
- 7.4.3.Product Portfolio
- 7.4.4.SWOT Analysis
- 7.4.5.Key Strategies and Developments
- 7.5.R&D Systems Inc.
- 7.5.1.Company Overview
- 7.5.2.Financial Highlights
- 7.5.3.Product Portfolio
- 7.5.4.SWOT Analysis
- 7.5.5.Key Strategies and Developments
- 7.6.Thermo Fisher Scientific Inc.
- 7.6.1.Company Overview
- 7.6.2.Financial Highlights
- 7.6.3.Product Portfolio
- 7.6.4.SWOT Analysis
- 7.6.5.Key Strategies and Developments
- 7.7.Elabscience Biotechnology Inc.
- 7.7.1.Company Overview
- 7.7.2.Financial Highlights
- 7.7.3.Product Portfolio
- 7.7.4.SWOT Analysis
- 7.7.5.Key Strategies and Developments
- 7.8.Aviva Systems Biology Corporation
- 7.8.1.Company Overview
- 7.8.2.Financial Highlights
- 7.8.3.Product Portfolio
- 7.8.4.SWOT Analysis
- 7.8.5.Key Strategies and Developments
- 7.9.Wuhan USCN Business Co. Ltd.
- 7.9.1.Company Overview
- 7.9.2.Financial Highlights
- 7.9.3.Product Portfolio
- 7.9.4.SWOT Analysis
- 7.9.5.Key Strategies and Developments
- 7.10.Kamiya Biomedical Company
- 7.10.1.Company Overview
- 7.10.2.Financial Highlights
- 7.10.3.Product Portfolio
- 7.10.4.SWOT Analysis
- 7.10.5.Key Strategies and Developments
- 7.11.Randox Laboratories Ltd.
- 7.11.1.Company Overview
- 7.11.2.Financial Highlights
- 7.11.3.Product Portfolio
- 7.11.4.SWOT Analysis
- 7.11.5.Key Strategies and Developments
- 7.12.Bio-Rad Laboratories Inc.
- 7.12.1.Company Overview
- 7.12.2.Financial Highlights
- 7.12.3.Product Portfolio
- 7.12.4.SWOT Analysis
- 7.12.5.Key Strategies and Developments
- 7.13.Eagle Biosciences Inc.
- 7.13.1.Company Overview
- 7.13.2.Financial Highlights
- 7.13.3.Product Portfolio
- 7.13.4.SWOT Analysis
- 7.13.5.Key Strategies and Developments
- 7.14.Biocompare
- 7.14.1.Company Overview
- 7.14.2.Financial Highlights
- 7.14.3.Product Portfolio
- 7.14.4.SWOT Analysis
- 7.14.5.Key Strategies and Developments
- 8.Assumptions and Acronyms
- 9.Research Methodology
- 10.Contact
- ondemand_videoVideos
- 74578
-
US $6,000US $3,999
-
US $8,000US $5,999
-
US $10,000US $6,999
- Mabtech AB
- Abcam plc.
- R&D Systems Inc.
- Thermo Fisher Scientific Inc.
- Elabscience Biotechnology Inc.
- Aviva Systems Biology Corporation
- Wuhan USCN Business Co. Ltd.
- Kamiya Biomedical Company
- Randox Laboratories Ltd.
- Bio-Rad Laboratories Inc.
- Eagle Biosciences Inc.
- Biocompare
- settingsSettings